New protein-based nano-switches could lead to faster, more accurate diagnostic tests

FHS
July 27, 2023
5:54 pm

QUT researchers have developed a new approach for designing molecular ON-OFF switches based on proteins which can be used in a multitude of biotechnological, biomedical and bioengineering applications.

CStone’s sugemalimab recommended for metastatic NSCLC

CStone has already secured sugemalimab’s approval in China for five cancer indications. Credit: Marko Aliaksandr/Shutterstock.com. The European Medicines Agency’s (EMA) Committee for Medicinal Products for

June 3, 2024

Fecal microbiota transplantation boosts survival in metastatic colorectal cancer treatment

A recent study in eClinicalMedicine found that fecal microbiota transplantation, combined with fruquintinib and tislelizumab, significantly improved survival rates in patients with microsatellite stable metastatic

November 16, 2023

UnitedHealthcare Donates $2.85M for Direct Service Workers in Indiana

What You Should Know: UnitedHealthcare Community Plan of Indiana has provided $2.85M to four organizations working to advance the direct service health workforce in the

August 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.